Sarepta Therapeutics
SRPT
SRPT
371 hedge funds and large institutions have $8.48B invested in Sarepta Therapeutics in 2019 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 142 increasing their positions, 115 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
371
Holders Change
+36
Holders Change %
+10.75%
% of All Funds
8.04%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
72
Increased
142
Reduced
115
Closed
35
Calls
$363M
Puts
$283M
Net Calls
+$79.9M
Net Calls Change
-$16.7M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$104M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$98.5M |
| 3 |
O
OppenheimerFunds
New York
|
+$76.5M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
+$62.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.7M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$100M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$83.5M |
| 3 |
BlackRock
New York
|
-$78.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$71.8M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$40.4M |
